(Q74619625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

extranodal NK/T-cell lymphoma, nasal type

12 November 2019

main subject

1 reference

Michael M C Cheung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

John K C Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Wai-hon Lau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Roger K C Ngan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

William W L Foo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

182-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Primary nasal and nasopharyngeal lymphomas: a comparative study of clinical presentation and treatment outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

CD56+ NK lymphomas: clinicopathological features and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Treatment of lethal midline granuloma type nasal T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Treatment outcome and prognostic factors for primary nasal lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Nasal and nasal-type natural killer/T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Expression of natural killer cell markers in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Aggressive T/natural killer cell lymphoma presenting as testicular tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902916-4

7 January 2021

10.1016/S0360-3016(02)02916-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12182990%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference